Inspire Medical Systems (NYSE: INSP) reported Q4 EPS of ($0.09), $0.35 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $78.4 million versus the consensus estimate of $78.11 million.

GUIDANCE:

Inspire Medical Systems sees FY2022 revenue of $318-326 million, versus the consensus of $312.8 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.